STOCK TITAN

Scilex (NASDAQ: SCLX) OKs director, auditor and larger equity plan

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Scilex Holding Company reported voting results from its 2026 annual stockholder meeting. All Series A preferred shares, totaling 29,057,097, and 5,389,081 common shares were represented, based on 8,491,267 common shares outstanding as of April 28, 2026.

Stockholders elected Dorman Followwill as a Class I director, ratified BPM LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved an amendment to the 2022 Equity Incentive Plan. The plan’s share reserve was increased by 1,300,000 shares to 2,765,789 shares, including the same total available for incentive stock options.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Series A preferred represented 29,057,097 shares 100% of Series A Preferred Stock at June 24, 2026 meeting
Common shares represented 5,389,081 shares Approximately 63.5% of 8,491,267 common shares outstanding as of April 28, 2026
Common shares outstanding 8,491,267 shares Common Stock issued and outstanding as of April 28, 2026
Series A voting power 848,106 votes Aggregate votes on an as-converted basis for Series A Preferred Stock
Director election votes for 3,945,473 votes Votes for Dorman Followwill as Class I director
Auditor ratification support 5,956,622 votes for Ratification of BPM LLP for fiscal year ending December 31, 2026
Equity plan increase 1,300,000 shares Increase in shares authorized under 2022 Equity Incentive Plan
Total plan shares after amendment 2,765,789 shares Total shares authorized and ISO limit under 2022 Equity Incentive Plan
Series A Preferred Stock financial
"29,057,097 shares of the Company’s Series A preferred stock, $0.0001 par value per share (the “Series A Preferred Stock”)"
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
Broker Non-Votes financial
"Dorman Followwill | 3,945,473 | 410,969 | 1,880,745"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"To ratify the appointment of BPM LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
2022 Equity Incentive Plan financial
"To approve the amendment to the Company’s 2022 Equity Incentive Plan (as amended) to (i) increase the number of shares authorized"
ISOs financial
"and (ii) increase the number of shares authorized for issuance thereunder pursuant to the exercise of ISOs to 2,765,789 shares."
ISOs, or incentive stock options, are grants that let employees buy company shares at a set price after a waiting period, similar to a bonus paid in stock rather than cash. They matter to investors because exercising ISOs can increase the number of shares outstanding (diluting existing owners) and signal employee commitment—both of which affect future earnings per share and the company’s long-term value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false00018201900001820190sclx:WarrantsToPurchaseOneShareOfCommonStockEachAtAnExercisePriceOf40250PerShareMember2026-06-242026-06-2400018201902026-06-242026-06-240001820190sclx:CommonStockParValue00001PerShare2Member2026-06-242026-06-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_______________________

FORM 8-K
_______________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 24, 2026

_______________________

SCILEX HOLDING COMPANY
(Exact name of registrant as specified in its charter)

_______________________

Delaware
(State or other jurisdiction
of incorporation)

001-39852
(Commission
File Number)

92-1062542
(IRS Employer
Identification No.)

 

960 San Antonio Road, Palo Alto, California, 94303
(Address of principal executive offices, including zip code)

(650) 516-4310

Registrant’s telephone number, including area code

N/A
(Former Name or Former Address, if Changed Since Last Report)

_______________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

(Title of each class)

(Trading Symbol)

(Name of exchange on which registered)

Common Stock, par value $0.0001 per share

SCLX

The Nasdaq Stock Market LLC

Warrants to purchase one share of common stock, each at an exercise price of $402.50

SCLXW

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 24, 2026, Scilex Holding Company (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Meeting”). At the Meeting, a total of (i) 29,057,097 shares of the Company’s Series A preferred stock, $0.0001 par value per share (the “Series A Preferred Stock”), or 100% of the 29,057,097 shares of Series A Preferred Stock, issued and outstanding, and (ii) 5,389,081 shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), or approximately 63.5% of the 8,491,267 shares of Common Stock, issued and outstanding, both as of the close of business on April 28, 2026, the record date for the Meeting, were represented virtually or by proxy.

The holder of Series A Preferred Stock was entitled to vote, together with the holders of Common Stock and not separately as a class, on an as converted to Common Stock basis for an aggregate of 848,106 votes as a result of the adjustments to the deemed conversion price of such preferred stock in accordance with the Certificate of Designations of Series A Preferred Stock, filed with the Delaware Secretary of State on November 10, 2022.

At the Meeting, the Company’s stockholders considered three proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 30, 2026.

Set forth below is a brief description of each proposal voted upon at the Meeting and the voting results with respect to each proposal.

Proposal No. 1: To elect the following nominee as a Class I director to serve until the Company’s 2029 Annual Meeting of Stockholders.

Nominee

For

Withhold

Broker Non-Votes

Dorman Followwill

3,945,473

410,969

1,880,745

 

Proposal No. 2: To ratify the appointment of BPM LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.

For

Against

Abstentions

5,956,622

207,998

72,567

 

Proposal No. 3: To approve the amendment to the Company’s 2022 Equity Incentive Plan (as amended) to (i) increase the number of shares authorized for issuance thereunder by 1,300,000 shares to 2,765,789 shares and (ii) increase the number of shares authorized for issuance thereunder pursuant to the exercise of ISOs to 2,765,789 shares.

For

Against

Abstentions

Broker Non-Votes

3,337,435

1,009,991

9,016

1,880,745

 

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number

Description

104

Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).

 

2

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SCILEX HOLDING COMPANY

 

 

 

 

By:

/s/ Henry Ji, Ph.D.

 

Name:

Henry Ji, Ph.D.

Date: June 24, 2026

Title:

Chief Executive Officer & President

 

3

 


FAQ

What key decisions were made at Scilex (SCLX) at the 2026 annual meeting?

Stockholders elected Dorman Followwill as a Class I director, ratified BPM LLP as independent auditor for 2026, and approved expanding the 2022 Equity Incentive Plan share reserve to 2,765,789 shares, including the same limit for incentive stock options.

How many Scilex (SCLX) shares were represented at the 2026 annual meeting?

The meeting represented 29,057,097 Series A preferred shares, equal to 100% of that class, and 5,389,081 common shares. The common tally reflects about 63.5% of 8,491,267 common shares outstanding as of the April 28, 2026 record date.

Was Scilex director nominee Dorman Followwill elected at the 2026 meeting?

Yes. Dorman Followwill received 3,945,473 votes in favor, 410,969 votes withheld, and 1,880,745 broker non-votes. He will serve as a Class I director until Scilex’s 2029 annual meeting of stockholders, according to the disclosed voting results.

Which auditor did Scilex (SCLX) stockholders ratify for fiscal 2026?

Stockholders ratified BPM LLP as Scilex’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The ratification received 5,956,622 votes for, 207,998 against, and 72,567 abstentions, indicating broad support among participating shares.

What changes were approved to Scilex’s 2022 Equity Incentive Plan?

Stockholders approved increasing shares authorized under the 2022 Equity Incentive Plan by 1,300,000 to 2,765,789 shares. The number of shares available for incentive stock options was also raised to 2,765,789, with 3,337,435 votes for and 1,009,991 against.

How many votes did the Scilex equity plan amendment receive?

The equity incentive plan amendment received 3,337,435 votes for, 1,009,991 against, and 9,016 abstentions, with 1,880,745 broker non-votes. This outcome shows a majority of voting shares supported the increased share reserve and updated incentive stock option limit.

Filing Exhibits & Attachments

1 document